Tetrindole was a drug candidate that functions by reversibly inhibiting monoamine oxidase A; it was first synthesized in Moscow in the early 1990s.

[1] Tetrindole is similar in its chemical structure to pirlindole (Pyrazidol), and metralindole.

[2] This drug article relating to the nervous system is a stub.

You can help Wikipedia by expanding it.